| clinical trial | Q30612 |
| P3098 | ClinicalTrials.gov ID | NCT02706223 |
| P17 | country | United Kingdom | Q145 |
| P582 | end time | 2019-01-01 | |
| P1050 | medical condition | hepatitis | Q131742 |
| hepatitis C | Q154869 | ||
| P1132 | number of participants | 300 | |
| P6153 | research site | NHS Grampian | Q6954137 |
| NHS Tayside | Q6954176 | ||
| P1813 | short name | SuperDOT-C | |
| P580 | start time | 2016-12-01 | |
| P8363 | study type | interventional study | Q78089383 |
| P1476 | title | A Cluster Randomised Trial of Pharmacy Led HCV Therapy Versus Conventional Treatment Pathways for HCV Positive Patients Receiving Daily OST in Pharmacies in Health Boards Within NHS Scotland |